the ability of plasma p-tau231 to detect preclinical alzheimer’s disease
Published 2 years ago • 218 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
3:13
plasma p-tau181 and p-tau231 offer complementary information in alzheimer's
-
3:09
head-to-head comparison of p-tau species for alzheimer’s disease detection in a real-world cohort
-
2:46
value of p-tau231 in early alzheimer’s disease
-
2:47
latest knowledge on plasma p-tau in alzheimer’s disease
-
5:19
examining plasma vs. csf p-tau217 in preclinical and prodromal alzheimer’s disease
-
1:36
using plasma biomarkers in the diagnosis of alzheimer’s disease
-
1:02
differences between alzheimer’s disease biomarkers: p-tau181, p-tau231 & p-tau217
-
2:11
upcoming plasma biomarkers for alzheimer’s disease: aβ, p-tau and gfap
-
1:32
investigating novel plasma-based p-tau biomarkers
-
1:14
plasma tau levels and alzheimer’s disease: what’s the relationship?
-
2:57
the potential of plasma biomarkers in dementia
-
1:58
the value of plasma p-tau181 as a screening and diagnostic tool for alzheimer’s disease
-
1:12
beyond aβ and p-tau: novel biomarkers under investigation for alzheimer’s disease
-
4:07
plasma versus neuroimaging biomarkers for alzheimer’s disease clinical trials
-
3:19
prognostic blood biomarkers in the pre-clinical stages of alzheimer’s disease
-
1:57
plasma p-tau181 to identify alzheimer’s disease-related co-pathology in dlb
-
1:23
plasma biomarkers for alzheimer's disease as pre-screening tools
-
1:49
nfl as a biomarker in alzheimer’s
-
1:45
the accuracy of plasma biomarkers for alzheimer’s disease outside of a controlled setting